ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evotec Buys Kinaxo, Works With ChemBridge

by Michael McCoy
February 21, 2011 | APPEARED IN VOLUME 89, ISSUE 8

The German contract research organization Evotec has acquired Kinaxo, a Munich-based company that offers technologies for response prediction and safety assessment in drug development. Evotec will pay about $16 million and could make $5 million in additional payments depending on Kinaxo’s performance. Separately, Evotec will work with ChemBridge to expand its screening library. Evotec will enhance its library of 250,000 druglike compounds with an initial 110,000 compounds from ChemBridge.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment